Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
40,31 USD | -3,17 % | -6,19 % | -12,48 % |
Kurzporträt
Mitarbeiterzahl: 255
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Ian Mortimer
CEO | Chief Executive Officer | 48 | 21.10.13 |
Simon Pimstone
FOU | Founder | 56 | 05.11.96 |
Sherry Aulin
DFI | Director of Finance/CFO | 40 | 01.01.11 |
Chief Tech/Sci/R&D Officer | - | 23.08.21 | |
Sheila M. Grant
CTO | Chief Tech/Sci/R&D Officer | - | 01.08.20 |
Jodi Regts
IRO | Public Communications Contact | - | 01.12.15 |
Corporate Officer/Principal | - | 17.08.20 | |
Andrea DiFabio
LAW | General Counsel | 55 | 07.11.22 |
James Empfield
PRN | Corporate Officer/Principal | - | 01.02.16 |
Corporate Officer/Principal | 63 | 01.03.01 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Clarence Machado
BRD | Director/Board Member | 60 | 05.11.20 |
Mohammad Azab
BRD | Director/Board Member | 68 | 01.10.03 |
Justin Gover
BRD | Director/Board Member | 53 | 08.08.23 |
Gary Patou
BRD | Director/Board Member | 65 | 01.01.04 |
Simon Pimstone
FOU | Founder | 56 | 05.11.96 |
Steven Gannon
BRD | Director/Board Member | 62 | 21.05.15 |
Ian Mortimer
CEO | Chief Executive Officer | 48 | 21.10.13 |
Dawn Svoronos
BRD | Director/Board Member | 70 | 27.09.16 |
Director/Board Member | 66 | 03.06.21 | |
Gillian Cannon
BRD | Director/Board Member | 60 | 08.08.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 75 432 482 | 74 047 334 ( 98,16 %) | 0 | 98,16 % |
Unternehmenskontakt
Xenon Pharmaceuticals, Inc.
3650 Gilmore Way Suite 200
V5G 4W8, Burnaby
+604 484 3300
http://www.xenon-pharma.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-12,48 % | 3,14 Mrd. | |
-3,30 % | 102 Mrd. | |
+1,79 % | 96,84 Mrd. | |
-0,44 % | 21,48 Mrd. | |
-18,35 % | 20,82 Mrd. | |
-7,45 % | 18,6 Mrd. | |
-40,31 % | 16,81 Mrd. | |
-26,84 % | 13,78 Mrd. | |
+0,59 % | 13,4 Mrd. | |
+20,86 % | 11,06 Mrd. |
- Börse
- Aktien
- A12ETN Aktie
- Unternehmen Xenon Pharmaceuticals Inc.